Kinase inhibition--a new approach to the treatment of rheumatoid arthritis
- PMID: 22873537
- DOI: 10.1056/NEJMe1206315
Kinase inhibition--a new approach to the treatment of rheumatoid arthritis
Comment on
-
Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis.N Engl J Med. 2012 Aug 9;367(6):495-507. doi: 10.1056/NEJMoa1109071. N Engl J Med. 2012. PMID: 22873530 Clinical Trial.
-
Tofacitinib or adalimumab versus placebo in rheumatoid arthritis.N Engl J Med. 2012 Aug 9;367(6):508-19. doi: 10.1056/NEJMoa1112072. N Engl J Med. 2012. PMID: 22873531 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical